| Schedule of Recognized Identified Assets Acquired and Liabilities Assumed [Table Text Block] |
| |
|
Preliminary
Allocation at
Acquisition
Date |
|
|
Adjustments to Fair Value |
|
|
Final Allocation at June 30, 2021 |
| Current assets, net of cash |
|
$ |
3,145 |
|
|
$ |
- |
|
|
$ |
3,145 |
| Equipment and other long-term assets |
|
|
1,639 |
|
|
|
- |
|
|
|
1,639 |
| Intangible assets: |
|
|
|
|
|
|
|
|
|
|
|
| Developed technology |
|
|
6,778 |
|
|
|
- |
|
|
|
6,778 |
| Customer relationships |
|
|
2,133 |
|
|
|
- |
|
|
|
2,133 |
| Goodwill |
|
|
8,811 |
|
|
|
(963 |
) |
|
|
7,848 |
| Total assets acquired |
|
|
22,506 |
|
|
|
(963 |
) |
|
|
21,543 |
| Liabilities |
|
|
1,436 |
|
|
|
- |
|
|
|
1,436 |
| Deferred income taxes, net |
|
|
2,320 |
|
|
|
(963 |
) |
|
|
1,357 |
| Net assets acquired |
|
$ |
18,750 |
|
|
$ |
- |
|
|
$ |
18,750 |
| |
|
|
|
|
|
|
|
|
|
|
|
| Cash paid, net of cash acquired |
|
|
9,765 |
|
|
|
- |
|
|
|
9,765 |
| Fair value of noncontrolling interest in Eminence |
|
|
8,985 |
|
|
|
- |
|
|
|
8,985 |
| Net assets acquired |
|
$ |
18,750 |
|
|
$ |
- |
|
|
$ |
18,750 |
| |
|
|
|
Preliminary allocation at acquisition date and at June 30, 2021 |
| Current assets, net of cash |
|
|
|
$ |
10,422 |
| Equipment and other long-term assets |
|
|
|
|
3,762 |
| Intangible assets: |
|
|
|
|
|
| Developed technology |
|
|
|
|
107,000 |
| In-process research and development |
|
|
|
|
22,700 |
| Customer relationships |
|
|
|
|
11,700 |
| Tradenames |
|
|
|
|
2,000 |
| Non-competition agreement |
|
|
|
|
1,000 |
| Goodwill |
|
|
|
|
94,970 |
| Total assets acquired |
|
|
|
|
253,554 |
| |
|
|
|
|
|
| Liabilities |
|
|
|
|
4,003 |
| Deferred income taxes, net |
|
|
|
|
15,664 |
| Net assets acquired |
|
|
|
$ |
233,887 |
| |
|
|
|
|
|
| Cash paid, net of cash acquired |
|
|
|
|
215,587 |
| Contingent consideration payable |
|
|
|
|
18,300 |
| Net assets acquired |
|
|
|
$ |
233,887 |
| |
|
B-MoGen Biotechnologies |
|
|
Exosome Diagnostics |
|
|
Quad Technologies |
| Current assets, net of cash |
|
$ |
504 |
|
|
$ |
2,611 |
|
|
$ |
36 |
| Equipment and other long-term assets |
|
|
269 |
|
|
|
2,212 |
|
|
|
228 |
| Intangible assets: |
|
|
|
|
|
|
|
|
|
|
|
| Developed technology |
|
|
14,000 |
|
|
|
105,000 |
|
|
|
12,256 |
| Trade name |
|
|
- |
|
|
|
58,000 |
|
|
|
- |
| Customer relationships |
|
|
400 |
|
|
|
2,300 |
|
|
|
- |
| Goodwill |
|
|
16,131 |
|
|
|
105,362 |
|
|
|
14,481 |
| Total assets acquired |
|
|
31,304 |
|
|
|
275,485 |
|
|
|
27,001 |
| |
|
|
|
|
|
|
|
|
|
|
|
| Liabilities |
|
|
211 |
|
|
|
3,716 |
|
|
|
296 |
| Deferred income taxes, net |
|
|
3,051 |
|
|
|
16,346 |
|
|
|
943 |
| Net assets acquired |
|
$ |
28,042 |
|
|
$ |
255,423 |
|
|
$ |
25,762 |
| |
|
|
|
|
|
|
|
|
|
|
|
| Cash paid, net of cash acquired |
|
|
17,448 |
|
|
|
251,623 |
|
|
|
20,462 |
| Additional consideration(1) |
|
|
10,594 |
|
|
|
3,800 |
|
|
|
5,300 |
| Net assets acquired |
|
$ |
28,042 |
|
|
$ |
255,423 |
|
|
$ |
25,762 |
|